Provided by Tiger Trade Technology Pte. Ltd.

BioRestorative Therapies, Inc.

1.05
+0.00500.48%
Post-market: 0.8828-0.1622-15.52%19:51 EST
Volume:86.19K
Turnover:90.19K
Market Cap:9.28M
PE:-0.71
High:1.07
Open:1.05
Low:1.02
Close:1.04
52wk High:2.50
52wk Low:0.9841
Shares:8.88M
Float Shares:4.92M
Volume Ratio:3.50
T/O Rate:1.75%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4754
EPS(LYR):-1.1565
ROE:-207.73%
ROA:-89.73%
PB:4.23
PE(LYR):-0.90

Loading ...

BioRestorative Therapies Inc. unveils regenerative medicine pipeline and commercial plans in new investor presentation

Reuters
·
Nov 22, 2025

BioRestorative Therapies files to sell 508,592 shares of common stock for holder

TIPRANKS
·
Nov 19, 2025

BioRestorative Therapies Inc - Type B Meeting Scheduled for Mid-December

THOMSON REUTERS
·
Nov 17, 2025

BioRestorative Granted Type B Meeting with FDA to Discuss Accelerated BLA Approval Pathway for BRTX-100 in Chronic Lumbar Disc Disease

GlobeNewswire
·
Nov 17, 2025

BioRestorative Therapies Q3 EPS $(0.33) Beats $(0.36) Estimate, Sales $11.800K Miss $460.000K Estimate

Benzinga
·
Nov 13, 2025

BioRestorative Therapies Q3 Net Income USD -3 Million

THOMSON REUTERS
·
Nov 13, 2025

BioRestorative Therapies Reports Third Quarter 2025 Financial Results and Provides Business Update

GlobeNewswire
·
Nov 13, 2025

BioRestorative Therapies Inc expected to post a loss of 36 cents a share - Earnings Preview

Reuters
·
Nov 07, 2025

BioRestorative Therapies Says Granted Japanese Patent Allowance for Stem Cell Technology; Shares Up Pre-Bell

MT Newswires Live
·
Oct 27, 2025

BioRestorative Therapies Inc - Protected in Developing Alternatives to Glp-1 Drugs

THOMSON REUTERS
·
Oct 27, 2025

BioRestorative Awarded Notice of Allowance for Japanese Patent – Expands Protection for Potential Cell-Based Alternative to Multi-Billion Dollar GLP-1 Drug Market

GlobeNewswire
·
Oct 27, 2025

BioRestorative Therapies names Crystal Romano head, global commercial operations

TIPRANKS
·
Oct 22, 2025

BioRestorative Strengthens Commercial Leadership With Appointment of Crystal Romano as Head of Global Commercial Operations to Accelerate Growth of Cell-Based Product Portfolio

THOMSON REUTERS
·
Oct 22, 2025

BioRestorative Therapies to Participate in the 2025 Maxim Growth Summit

GlobeNewswire
·
Oct 15, 2025

BioRestorative Therapies announces 1085 million registered direct offering and concurrent private placement of warrants

Reuters
·
Oct 09, 2025

BioRestorative Therapies announces $1.085M registered direct offering

TIPRANKS
·
Oct 07, 2025

BioRestorative Therapies Announces $1.085 Million Registered Direct Offering Priced Above Market

GlobeNewswire
·
Oct 07, 2025

BioRestorative Therapies Inc. Held Annual Meeting of Stockholders

Reuters
·
Sep 25, 2025

BioRestorative Therapies Inc. Unveils Investor Presentation on Regenerative Medicine Advances

Reuters
·
Sep 05, 2025

BioRestorative Therapies Inc. Unveils Investor Presentation Focused on Regenerative Medicine Innovations

Reuters
·
Aug 14, 2025